Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells

被引:13
|
作者
Chu, Carolyn [1 ]
Armenia, Daniele [2 ]
Walworth, Charles [3 ]
Santoro, Maria M. [4 ]
Shafer, Robert W. [5 ]
机构
[1] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA
[2] St Camillus Int Univ Hlth Sci, UniCamillus, Rome, Italy
[3] Lab Corp Monogram Biosci, South San Francisco, CA USA
[4] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy
[5] Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA
关键词
antiviral therapy; DNA sequencing; HIV-1; peripheral blood mononuclear cells; provirus; adaptive mutations; drug resistance evolution; LOW-LEVEL VIREMIA; CD4(+) T-CELLS; ACTIVE ANTIRETROVIRAL THERAPY; RILPIVIRINE/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE; DRUG-RESISTANCE; HIV-1-INFECTED PATIENTS; PROVIRAL DNA; LATENT RESERVOIR; TREATMENT INTERRUPTION; VIROLOGICAL FAILURE;
D O I
10.1128/cmr.00052-22
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
HIV-1 DNA exists in nonintegrated linear and circular episomal forms and as integrated proviruses. In patients with plasma viremia, most peripheral blood mononuclear cell (PBMC) HIV-1 DNA consists of recently produced nonintegrated virus DNA while in patients with prolonged virological suppression (VS) on antiretroviral therapy (ART), most PBMC HIV-1 DNA consists of proviral DNA produced months to years earlier. Drug-resistance mutations (DRMs) in PBMCs are more likely to coexist with ancestral wild-type virus populations than they are in plasma, explaining why next-generation sequencing is particularly useful for the detection of PBMC-associated DRMs. In patients with ongoing high levels of active virus replication, the DRMs detected in PBMCs and in plasma are usually highly concordant. However, in patients with lower levels of virus replication, it may take several months for plasma virus DRMs to reach detectable levels in PBMCs. This time lag explains why, in patients with VS, PBMC genotypic resistance testing (GRT) is less sensitive than historical plasma virus GRT, if previous episodes of virological failure and emergent DRMs were either not prolonged or not associated with high levels of plasma viremia. Despite the increasing use of PBMC GRT in patients with VS, few studies have examined the predictive value of DRMs on the response to a simplified ART regimen. In this review, we summarize what is known about PBMC HIV-1 DNA dynamics, particularly in patients with suppressed plasma viremia, the methods used for PBMC HIV-1 GRT, and the scenarios in which PBMC GRT has been used clinically. HIV-1 DNA exists in nonintegrated linear and circular episomal forms and as integrated proviruses. In patients with plasma viremia, most peripheral blood mononuclear cell (PBMC) HIV-1 DNA consists of recently produced nonintegrated virus DNA while in patients with prolonged virological suppression (VS) on antiretroviral therapy (ART), most PBMC HIV-1 DNA consists of proviral DNA produced months to years earlier.
引用
收藏
页数:30
相关论文
共 50 条
  • [1] Isolation and propagation of HIV-1 on peripheral blood mononuclear cells
    van 't Wout, Angelique B.
    Schuitemaker, Hanneke
    Kootstra, Neeltje A.
    [J]. NATURE PROTOCOLS, 2008, 3 (03) : 363 - 370
  • [2] Isolation and propagation of HIV-1 on peripheral blood mononuclear cells
    Angélique B van 't Wout
    Hanneke Schuitemaker
    Neeltje A Kootstra
    [J]. Nature Protocols, 2008, 3 : 363 - 370
  • [3] PROGRESSION OF HIV-1 INFECTION - MONITORING OF HIV-1 DNA IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS BY PCR
    HUFERT, FT
    VONLAER, D
    FENNER, TE
    SCHWANDER, S
    KERN, P
    SCHMITZ, H
    [J]. ARCHIVES OF VIROLOGY, 1991, 120 (3-4) : 233 - 240
  • [4] DNA AMPLIFICATION FOR DIRECT DETECTION OF HIV-1 IN DNA OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS
    OU, CY
    KWOK, S
    MITCHELL, SW
    MACK, DH
    SNINSKY, JJ
    KREBS, JW
    FEORINO, P
    WARFIELD, D
    SCHOCHETMAN, G
    [J]. SCIENCE, 1988, 239 (4837) : 295 - 297
  • [5] Genotypic prediction of HIV-1 tropism from plasma and peripheral blood mononuclear cells in the clinical routine laboratory
    Paar, Christian
    Geit, Maria
    Stekel, Herbert
    Berg, Joerg
    [J]. ADVANCES IN CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, : 42 - 45
  • [6] Lack of evidence for complete resistance of peripheral blood mononuclear cells to HIV-1 and HIV-2 infection
    Al-Jabri, Ali A.
    Lambkin, Robert
    Oxford, John S.
    [J]. VIRAL IMMUNOLOGY, 2008, 21 (01) : 83 - 90
  • [7] Desialylation of peripheral blood mononuclear cells promotes growth of HIV-1
    Stamatos, NM
    Gomatos, PJ
    Cox, J
    Fowler, A
    Dow, N
    Wohlhieter, JA
    Cross, AS
    [J]. VIROLOGY, 1997, 228 (02) : 123 - 131
  • [8] Genotypic testing for HIV-1 drug resistance using dried blood samples
    Rosalia Lira
    Hilda Valdez-Salazar
    Guillermo Vazquez-Rosales
    Othon Rojas-Montes
    Martha Ruiz-Tachiquin
    Rocio Torres-Ibarra
    Carlos Cano-Dominguez
    Angelica Maldonado-Rodríguez
    Alejandro Gomez
    Onofre Muñoz
    Ma-Teresa Alvarez-Muñoz
    [J]. Archives of Virology, 2010, 155 : 1117 - 1125
  • [9] Genotypic testing for HIV-1 drug resistance using dried blood samples
    Lira, Rosalia
    Valdez-Salazar, Hilda
    Vazquez-Rosales, Guillermo
    Rojas-Montes, Othon
    Ruiz-Tachiquin, Martha
    Torres-Ibarra, Rocio
    Cano-Dominguez, Carlos
    Maldonado-Rodriguez, Angelica
    Gomez, Alejandro
    Munoz, Onofre
    Alvarez-Munoz, Ma-Teresa
    [J]. ARCHIVES OF VIROLOGY, 2010, 155 (07) : 1117 - 1125
  • [10] GENOTYPIC PREDICTION OF HIV-1 CORECEPTOR TROPISM FROM PLASMA AND PERIPHERAL BLOOD MONONUCLEAR CELLS IN THE CLINICAL ROUTINE LABORATORY
    Paar, C.
    Geit, M.
    Stekel, H.
    Berg, J.
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S517 - S517